4//SEC Filing
Western Standard Partners QP, L.P. 4
Accession 0000899243-20-010463
CIK 0001274792other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 7:23 PM ET
Size
16.5 KB
Accession
0000899243-20-010463
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2020-04-06$3.00/sh+6,043$18,108→ 683,120 total(indirect: See Footnote) - Purchase
Common Stock
2020-04-03$2.60/sh+10,750$27,924→ 677,077 total(indirect: See Footnote)
Holdings
- 176,586(indirect: See Footnote)
Common Stock
Andersen Eric
DirectorOther
Transactions
- Purchase
Common Stock
2020-04-03$2.60/sh+10,750$27,924→ 677,077 total(indirect: See Footnote) - Purchase
Common Stock
2020-04-06$3.00/sh+6,043$18,108→ 683,120 total(indirect: See Footnote)
Holdings
- 176,586(indirect: See Footnote)
Common Stock
Western Standard LLC
Other
Transactions
- Purchase
Common Stock
2020-04-03$2.60/sh+10,750$27,924→ 677,077 total(indirect: See Footnote) - Purchase
Common Stock
2020-04-06$3.00/sh+6,043$18,108→ 683,120 total(indirect: See Footnote)
Holdings
- 176,586(indirect: See Footnote)
Common Stock
Transactions
- Purchase
Common Stock
2020-04-03$2.60/sh+10,750$27,924→ 677,077 total(indirect: See Footnote) - Purchase
Common Stock
2020-04-06$3.00/sh+6,043$18,108→ 683,120 total(indirect: See Footnote)
Holdings
- 176,586(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.46 to $2.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]The shares are directly held by WSP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.975 to $3.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
- [F4]The shares are directly held by WSP QP. The general partner of the Funds is Western Standard. The managing member of Western Standard and the portfolio manager to the Funds is Mr. Andersen. Each of Western Standard and Mr. Andersen disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001544857
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 7:23 PM ET
- Size
- 16.5 KB